Vault-13

MAAT PHARMA SACA

COMM · CUSIP 00BNRR5C1

1 institutional holders
1,3621.4k shares reported held*
$9.8kreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $7.16.

Biggest buyers

Propel Bio Management, LLC New +1,362+1.4k

Biggest sellers

None

Holders, Q2 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Propel Bio Management, LLC 0.01% of their portfolio Los Angeles, CA 1,3621.4k $9.8k $9.8k 0.01% New